Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ:OABI)

2.775 +0.535 (+23.88%)
Streaming Delayed Price Updated: 1:22 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OmniAb, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration
Via Investor Brand Network
News headline image
OmniAb to Report Second Quarter 2026 Financial Results on August 6
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Names Amechi Nwachuku Chief Operating Officer
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Participate in Three Upcoming Investor Conferences
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Report First Quarter 2026 Financial Results on May 7
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Participate at the Leerink Partners Global Healthcare Conference
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4
From OmniAb, Inc.
Via Business Wire
News headline image
Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Participate in Three Investor Conferences in November
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Report Third Quarter 2025 Financial Results on November 4
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Announces $30 Million Private Placement
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Report Second Quarter 2025 Financial Results on August 6
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Introduces the xPloration® Partner Access Program
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Participate in Five Upcoming Investor Conferences
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Announces Two New Appointments to its Board of Directors
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Report First Quarter 2025 Financial Results on May 8
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Report Fourth Quarter 2024 Financial Results on March 18
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb to Participate in Two Investor Conferences in March
From OmniAb, Inc.
Via Business Wire
News headline image
OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference
From OmniAb, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.